MedTrace Logo

Intravenous Fluids in Pediatric Migraine

NCT06182098 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2023-12-26

No results posted yet for this study

Summary

The goal of this clinical trial is to compare intravenous (IV) fluids in pediatric patients with migraine. The main questions it aims to answer are:

* Does a large amount of fluids (bolus) improve pain
* Does a large amount of fluids (bolus) reduce admissions to the hospital for migraine Participants will be asked to report their pain and have vital signs checked every 30 minutes for two hours.

Researchers will compare a large amount of fluids (bolus) to a small amount (half maintenance) to see if there is a difference in pain improvement.

Conditions

Interventions

OTHER

1/2 maintenance fluids

Patients will receive 1/2 maintenance normal saline (with a maximum of 50 mL/hr), over one hour.

DRUG

Ketorolac

0.5mg/kg, with a maximum of 30mg

DRUG

Diphenhydramine

0.5mg/kg, with a maximum of 25mg

DRUG

Prochlorperazine

0.15mg/kg, with a maximum of 10mg

OTHER

bolus

20mL/kg normal saline bolus, with a maximum of 1L, given over one hour

Sponsors & Collaborators

  • Dayton Children's Hospital

    lead OTHER

Principal Investigators

  • Jonathan Elliott, MD · Dayton Children's

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-27
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06182098 on ClinicalTrials.gov